载脂蛋白1重组兔单抗

Rrmab®兔单抗
2026-01-04~2026-02-28,RR26012026-01-04~2026-02-28,TR
载脂蛋白1重组兔单抗
货号:bsm-54473R
产品详情
相关标记
相关产品
相关文献
常见问题

概述

产品编号
bsm-54473R
产品类型
重组兔单抗
英文名称
CD95/FAS Recombinant Rabbit mAb
中文名称
载脂蛋白1重组兔单抗
英文别名
ALPS1A; APO-1; APT1; CD95; FAS1; FASTM; TNFRSF6; APO1; TNFR6; lpr; FasR; TNR6_HUMAN; FAS; Apo-1 antigen; Apoptosis-mediating surface antigen FAS; FASLG receptor; TNR6_MOUSE; TNR6_RAT;
抗体来源
Rabbit
免疫原
Recombinant protein human CD95/FAS
亚型
IgG
性状
Liquid
纯化方法
affinity purified by Protein A
克隆类型
Recombinant
克隆号
6F9
理论分子量
45 kDa
浓度
1mg/ml
储存液
0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
SWISS
Gene ID
保存条件
Shipped at 4℃. Store at -20℃ for one year. Avoid repeated freeze/thaw cycles.
注意事项
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产品介绍
FAS(也称作Apo-1;CD95;FasL receptor;TNFR)是一个含有死亡结构域的受体,是一型膜蛋白,属于TNF-R家族成员,具有诱导细胞凋亡的功能,广泛分布于许多不同类型的细胞,主要用于各种恶性肿瘤(包括:乳腺癌、肾细胞癌、胃癌、肺癌以及肝病等)的研究。分子量为:40-50kDa。

FAS的凋亡信号主要是通过与其胞浆区相关的死亡结构域蛋白FADD介导的。FAS与FasL结合后,FADD一方面通过C端的DD结合FAS, 另一方面通过N端的DED与Caspase-8 N端DED结合,通过Caspase-8诱导效应性Caspase 蛋白酶的激活,并最终导致细胞凋亡的发生。FAS主要表达于活化淋巴细胞、单核细胞、中性粒细胞和成纤维细胞等。

Fas又称作APO-1/CD95,属TNF受体家族。Fas基因编码产物为分子量45KD的跨膜蛋白,分布于胸腺细胞,激活的T和B淋巴细胞,巨噬细胞,肝、脾、肺、心、脑、肠、睾丸和卵巢细胞等。
Fas蛋白与Fas配体结合后,会激活caspase,导致靶细胞走向凋亡
背景资料
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains a death domain. It has been shown to play a central role in the physiological regulation of programmed cell death, and has been implicated in the pathogenesis of various malignancies and diseases of the immune system. The interaction of this receptor with its ligand allows the formation of a death-inducing signaling complex that includes Fas-associated death domain protein (FADD), caspase 8, and caspase 10. The autoproteolytic processing of the caspases in the complex triggers a downstream caspase cascade, and leads to apoptosis. This receptor has been also shown to activate NF-kappaB, MAPK3/ERK1, and MAPK8/JNK, and is found to be involved in transducing the proliferating signals in normal diploid fibroblast and T cells. Several alternatively spliced transcript variants have been described, some of which are candidates for nonsense-mediated mRNA decay (NMD). The isoforms lacking the transmembrane domain may negatively regulate the apoptosis mediated by the full length isoform. [provided by RefSeq, Mar 2011]
载脂蛋白1重组兔单抗

产品应用

应用已检合格种属预测种属推荐稀释比例
WBHuman1:500-2000

交叉反应

交叉反应: Human

相关产品

暂无相关产品

靶标

基因名
FAS
蛋白名
Tumor necrosis factor receptor superfamily member 6
亚基
Binds DAXX. Interacts with HIPK3. Part of a complex containing HIPK3 and FADD. Binds RIPK1 and FAIM2. Interacts with BRE and FEM1B. Interacts with FADD.
亚细胞定位
Isoform 1: Cell membrane; Single-pass type I membrane protein. Isoform 2, 3, 4, 5, 6: Secreted.
组织特异性
Isoform 1 and isoform 6 are expressed at equal levels in resting peripheral blood mononuclear cells. After activation there is an increase in isoform 1 and decrease in the levels of isoform 6.
翻译后修饰
N- and O-glycosylated. O-glycosylated with core 1 or possibly core 8 glycans.
疾病
Defects in FAS are the cause of autoimmune lymphoproliferative syndrome type 1A (ALPS1A) [MIM:601859]; also known as Canale-Smith syndrome (CSS). ALPS is a childhood syndrome involving hemolytic anemia and thrombocytopenia with massive lymphadenopathy and splenomegaly.
相似性
Contains 1 death domain.
Contains 3 TNFR-Cys repeats.
功能
Receptor for TNFSF6/FASLG. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. FAS-mediated apoptosis may have a role in the induction of peripheral tolerance, in the antigen-stimulated suicide of mature T-cells, or both. The secreted isoforms 2 to 6 block apoptosis (in vitro).

标记抗体

暂无标记数据

同靶标产品

暂无同靶标产品

相关文献

提示: 发表研究结果有使用 bsm-54473R 时请让我们知道,以便我们可以引用参考文章。作为回馈,资料提供者将获得我们送上的小礼品。

暂无相关文献

常见问题

暂无常见问题